Skip to content

Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS Study

Procalcitonin Reveals Early Dehiscence In Gastric Surgery: the PREDIGS Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02756455
Enrollment
100
Registered
2016-04-29
Start date
2015-01-31
Completion date
2016-12-31
Last updated
2016-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

gastric cancer, procalcitonin

Brief summary

Background. Gastric cancer surgery is associated with high risk for postoperative morbidity and mortality. Anastomotic leak (AL) is one of the worst complications associated with relevant short and long-term sequelae. Procalcitonin (PCT) is a biomarker used to monitor bacterial infections and guide antibiotic therapy and has been shown to have better predictive value of AL after colorectal surgery than C-reactive protein (CRP) and white blood cell count (WBC). Purpose. Investigators designed a monocentric pilot study to test if PCT might be a sensitive and reliable marker of AL after gastric surgery

Interventions

OTHERgastric cancer pts undergoing surgery

Measure PCT (procalcitonin), CRP (C-reactive protein) and WBC (white blood cell count) in 3rd and 5th postoperative day and registration of all intra and postoperative complications

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* patients undergoing all different kinds of gastric surgery (from partial to total gastrectomy) for cancer, WITH an anastomosis performed * elective setting

Exclusion criteria

* age \< 18 years * pregnant women * patients undergoing gastric surgery for benign disease or other kinds of gastric surgery without an anastomosis being performed

Design outcomes

Primary

MeasureTime frameDescription
% of patients with leaks after gastric surgery correctly identified by the biomarkers (PCT and CRP)2 yearsPCT: procalcitonin, CRP: C-reactive protein
% of patients without leaks after gastric surgery correctly identified by PCT and CRP2 yearsPCT: procalcitonin, CRP: C-reactive protein

Secondary

MeasureTime frameDescription
PCT cut-off that gives good negative predictive (NPV) value for leak after gastric surgery in 3rd POD2 yearsprocalcitonin (PCT) cuts-off in 3rd post-operative day (POD) with a good NPV
PCT cut-off that gives good negative predictive value for leak after gastric surgery in 5th POD2 yearsPCT cuts-off in 5th POD with a good NPV

Countries

Italy

Contacts

Primary ContactValentina Giaccaglia, MD
v.giaccaglia@gmail.com+393397882429

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026